General Information of the Compound
| Compound ID |
CP0860066
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-(2-(3,4-dimethoxybenzyl)pyrrolidin-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H26N4O3
|
||||||||||||||||||
| Molecular Weight |
406.486
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(C[C@@H]2CCCN2C(=O)c2cc(C)ccc2-n2nccn2)cc1OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H26N4O3/c1-16-6-8-20(27-24-10-11-25-27)19(13-16)23(28)26-12-4-5-18(26)14-17-7-9-21(29-2)22(15-17)30-3/h6-11,13,15,18H,4-5,12,14H2,1-3H3/t18-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PAVMRWBHAJVYTO-SFHVURJKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1